NCT01370694 2019-03-15
Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)
Merck Sharp & Dohme LLC
Phase 1 Terminated
Merck Sharp & Dohme LLC
Seattle Children's Hospital
Pfizer
Children's National Research Institute
SymBio Pharmaceuticals